Tareq Abadl: The Hidden Danger in a Blood Bag – When a Unit Looks ‘Wrong’
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“The Hidden Danger in a Blood Bag: When a Unit Looks ‘Wrong’
Did you know that if a blood bag contains visible clots or fibrin strands, it should not be transfused?
Many people think transfusion safety is only about ABO, Rh, and antibody testing — but sometimes the warning sign is something you can actually see with the naked eye.
Blood components are collected into bags containing anticoagulants to prevent clotting. However, clotting activation can still occasionally occur, leading to the formation of:
- Clots
- Fibrin strands
- Clumps or aggregates
- Abnormal discoloration or appearance
Why is this important?
Because visible clots or fibrin strands may indicate:
- Activation of the coagulation process
- Product quality deterioration
- Improper storage or handling
- Potential risk to the patient if transfused
That is why blood-bank personnel and transfusion services perform careful visual inspection before releasing blood products.
A unit may be rejected even if:
- The blood type is correct
- Compatibility testing is acceptable
- The label appears normal
If unusual findings are seen, the component should be:
- Returned to the transfusion service
- Investigated further
- Withheld from transfusion until deemed safe
Another important laboratory point:
Different blood components can show different abnormal appearances.
For example:
- RBC units can show clots, hemolysis, dark discoloration
- Plasma can show unusual turbidity or color change
- Platelets can show clumping or loss of the normal swirling appearance
This is one of the most fascinating parts of medical laboratory science in transfusion medicine:
Blood-bank safety is not only about compatibility testing — it also includes visual inspection, storage monitoring, quality control, and product release safety.”

Other posts featuring Tareq Abadl on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers